Literature DB >> 12960234

HIV-1 fitness and macrophages.

Maureen M Goodenow1, Stephanie L Rose, Daniel L Tuttle, John W Sleasman.   

Abstract

HIV-1 comprises a collection of closely related, but not identical, viruses or quasispecies. Fitness represents a selective advantage for propagation among populations of organisms competing in a particular environment and is an important characteristic of viruses because of a link between fitness and pathogenesis. Environmental differences based on the type of cell that is targeted for infection or the cell type that produces virus, impact fitness. CD4-expressing cells of lymphocyte or macrophage lineage are the principal host cells for HIV-1, although the milieu in lymphocytes is distinct from the macrophage environment from the perspective of cell half-life and activation, signal transduction and expression of coreceptors, and bioavailability of antiretroviral drugs. Multiple viral determinants, including entry via envelope glycoproteins, replication by reverse transcriptase, and virion maturation by protease activity, contribute to fitness in different cells and provide targets for current antiretroviral therapies. This review focuses on fitness of HIV-1 in macrophages and examines the impact of protease inhibitors on fitness of quasispecies and an unexplained discordance between fitness and pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960234     DOI: 10.1189/jlb.0403186

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  12 in total

1.  Clinical implications of discordant viral and immune outcomes following protease inhibitor containing antiretroviral therapy for HIV-infected children.

Authors:  Carina A Rodriguez; Sarah Koch; Maureen Goodenow; John W Sleasman
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

2.  HIV-1 Transmission, Replication Fitness and Disease Progression.

Authors:  Tasha Biesinger; Jason T Kimata
Journal:  Virology (Auckl)       Date:  2008-07-14

3.  Evolutionary game theoretic strategy for optimal drug delivery to influence selection pressure in treatment of HIV-1.

Authors:  Yu Wu; Mingjun Zhang; Jing Wu; Xiaopeng Zhao; Lijin Xia
Journal:  J Math Biol       Date:  2011-04-19       Impact factor: 2.259

4.  Multiple independent lineages of HIV-1 persist in breast milk and plasma.

Authors:  Rebecca R Gray; Marco Salemi; Amanda Lowe; Kyle J Nakamura; William D Decker; Moses Sinkala; Chipepo Kankasa; Connie J Mulligan; Donald M Thea; Louise Kuhn; Grace Aldrovandi; Maureen M Goodenow
Journal:  AIDS       Date:  2011-01-14       Impact factor: 4.177

5.  Longitudinal Analysis of Cerebrospinal Fluid and Plasma HIV-1 Envelope Sequences Isolated From a Single Donor with HIV Asymptomatic Neurocognitive Impairment.

Authors:  Fabián Vázquez-Santiago; Yashira García; Ivelisse Rivera-Román; Richard J Noel; Valerie Wojna; Loyda M Meléndez; Vanessa Rivera-Amill
Journal:  J Virol Antivir Res       Date:  2015

Review 6.  The impact of viral and host elements on HIV fitness and disease progression.

Authors:  Kenneth R Henry; Jan Weber; Miguel E Quiñones-Mateu; Eric J Arts
Journal:  Curr HIV/AIDS Rep       Date:  2007-02       Impact factor: 5.071

7.  Impact on genetic networks in human macrophages by a CCR5 strain of human immunodeficiency virus type 1.

Authors:  Carter R Coberley; James J Kohler; Joseph N Brown; Joseph T Oshier; Henry V Baker; Michael P Popp; John W Sleasman; Maureen M Goodenow
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 8.  Amphibian macrophage development and antiviral defenses.

Authors:  Leon Grayfer; Jacques Robert
Journal:  Dev Comp Immunol       Date:  2015-12-15       Impact factor: 3.636

9.  Divergent antiviral roles of amphibian (Xenopus laevis) macrophages elicited by colony-stimulating factor-1 and interleukin-34.

Authors:  Leon Grayfer; Jacques Robert
Journal:  J Leukoc Biol       Date:  2014-09-04       Impact factor: 4.962

10.  Macrophage polarization: convergence point targeted by mycobacterium tuberculosis and HIV.

Authors:  Geanncarlo Lugo-Villarino; Christel Vérollet; Isabelle Maridonneau-Parini; Olivier Neyrolles
Journal:  Front Immunol       Date:  2011-09-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.